Filter Results
:
(27)
Show Results For
-
All HBS Web
(71)
- News (27)
- Research (19)
- Multimedia (1)
- Faculty Publications (8)
Show Results For
-
All HBS Web
(71)
- News (27)
- Research (19)
- Multimedia (1)
- Faculty Publications (8)
Page 1 of
27
Results
→
Sort by
- 03 Aug 2010
- News
Analysis: Rare diseases lure Sanofi, other big drugmakers
- 01 Feb 1999
- News
Classmates Rally to Help Family Stricken with Rare Disease
entrepreneurial spirit, and fight disease of whatever kind." Less than a year later, those words took on a tragic relevance for Crowley and his wife, Aileen, when their 18-month-old daughter Megan was diagnosed with Pompe's disease, a...
View Details
- 15 Mar 2018
- News
Regeneron Talent Search Winners Cure Pessimism
- 01 Dec 2023
- News
Wide Horizon
There were three critical events that led John Rodakis (MBA 1997) to form the nonprofit N of One in 2014 and ultimately dedicate his life to surfacing breakthrough autism research. The first occurred on Thanksgiving of 2012. He had driven about four hours with his wife...
View Details
Keywords:
Dan Morrell; Photos by Sarah Wilson
- 01 Jun 2023
- News
From Big Pharma to Startup
Hunter Goble (MBA 2022) did not enroll in Harvard Business School with dreams of becoming an entrepreneur. After earning his MBA, Goble intended to return to Eli Lilly to continue to work building brands and launching products. He envisioned himself leading a big,...
View Details
Keywords:
April White
- 01 Oct 2021
- News
From Scholarship to Life-Saving Impact
Nora Rabah (MS/MBA 2022), who emigrated to the United States as a child, remembers the hardship of growing up without health care and wants to make drugs for children with rare diseases more accessible and...
View Details
- 31 Jan 2014
- News
Body, Heal Thyself
messenger RNA (mRNA) Therapeutics. The data that Bancel saw that evening were shocking. The numbers suggested Moderna had found an entirely new way to treat diseases—one that promised to change the medical world, resulting in cures for View Details
- 25 Aug 2022
- News
Up on the Corner
It’s a drab gray morning in April, and real estate developer Nadine Ngouabe Dlodlo (MBA 2008) is standing at the corner of West Baltimore and South Calhoun Streets in Baltimore’s historic Union Square district. Behind her, a chain-link fence decorated with a small...
View Details
- 25 Apr 2014
- News
A revolution in healing
formerly was CEO of bioMérieux. He joined the company in 2011 after seeing impressive data indicating Moderna had found an entirely new way to treat rare diseases and cancer—using technology that was...
View Details
- 01 Sep 2003
- News
Richard Edelman
well. Appointed the firm’s CEO in 1997, he believes that there is usually an intersection of corporate and public interest. “Change is rarely revolutionary,” he says cheerfully. “You do better by being inside the tent.” Since earning his...
View Details
- 01 Dec 2013
- News
Your Own Medicine
conference room at DART's Cambridge office. After several years in consulting and a few years launching start-ups, Williams spent eight years at Genzyme, managing its rare disease portfolio, leaving in 2006...
View Details
- 30 Jun 2017
- News
Rebuilding the Girl Scouts Brand
Goals. “I had that rare instance where my skill set as a marketer was being called on to meet a greater social need,” Pitter-Armand says. “I’d always enjoyed my work, but now I was waking up at 3 o’clock in the morning with new ideas.” As...
View Details
Keywords:
April White
- 23 Jan 2019
- News
The Promise of Personalized Medicine
muscle weakness and loss. MORE Watch a video about Horgan’s experience as a Blavatnik Fellow Read more about Cure Rare Disease MORE Watch a video about Horgan’s experience as a Blavatnik Fellow Read more...
View Details
- 24 Sep 2020
- News
The Race for a Vaccine
newly opened facility to accommodate its vaccine development work, and CEO Stéphane Bancel (MBA 2000, AMP 170) welcomed input on the design from the government’s infectious disease experts. For two years, Moderna had been working closely...
View Details
- 03 Mar 2017
- News
Big Blue’s Big Bet
doctors at least two weeks to sift through these mutations, searching for the ones that were diagnostically significant. But Watson was able to highlight within moments which mutated genes had likely developed into cancer. Based on Watson’s analysis, the treating...
View Details
Keywords:
Paul Kix; illustrations by Dan Page
- 06 Dec 2021
- News
Vision: Sound Science
doctorate in biomedical engineering and readily admits he still identifies as a scientist, is equally excited about the big-picture impact of receiving orphan drug and rare pediatric disease designations....
View Details
Keywords:
Deb Blagg
- 16 Jul 2019
- News
The Making of a Movement
proceeds from research specific to sarcoma—the disease Jen fought—to all rare cancers. The significance of that selfless shift was seismic. By loosening the link between Cycle for Survival and their own...
View Details
- 01 Mar 2006
- News
One-on-One with Dr. Margaret Chan
appointed Representative of the WHO Director-General for Pandemic Influenza last year. She also serves as Assistant Director-General for the Communicable Diseases Cluster. With so much at stake, what keeps Chan focused? “A sheer passion...
View Details
- 15 Dec 2015
- News
The Year in Ideas 2015
guilt and insecurity. NeuroPhage is a family business of sorts. Jonathan Solomon’s (MBA 2007) mother, Beka Solomon, chair for biotechnology of neurodegenerative diseases at Tel Aviv University, had spent years working with a virus that...
View Details